November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Sevan Kaloustian: Healthcare in Upper Egypt is advancing
Nov 22, 2024, 11:30

Sevan Kaloustian: Healthcare in Upper Egypt is advancing

Sevan Kaloustian, Vice President, Managing Director of JENA Cluster at Johnson & Johnson Innovative Medicine, shared a post on LinkedIn:

“Healthcare in Upper Egypt is advancing!

This week, Johnson and Johnson JENA Leadership Team and I had the privilege of visiting Luxor and witnessing firsthand the dedication toward improving healthcare in the region for millions of patients.

With Dr. Ahmed Al Borei, Head of the General Authority for Healthcare for Upper Egypt, we observed how Universal Healthcare Insurance is progressing and how the authority’s advanced system for data generation is monitoring and improving service to patients.

Also, our time at Shifa Al Orman Hospital – a state-of-the-art facility dedicated to serving cancer patients – has been memorable.

Hosted by Dr. Emad Shash, General Manager of the Breast Cancer Comprehensive Center of the National Cancer Institute, Cairo University, and Dr. Hany Hussein, General manager of Shifa Al Orman Hospital in Luxor, we witnessed the hospital’s exceptional facilities and compassionate care.

As we continue our mission to leave no patient behind, we are engaged to further contribute to elevating healthcare for patients in Upper Egypt.”

Sevan Kaloustian: Healthcare in Upper Egypt is advancing

For more posts like this visit oncodaily.com.

Sevan Kaloustian is Vice President and Managing Director of the JENA Cluster at Johnson & Johnson Innovative Medicine, overseeing a team of over 200 professionals across multiple countries focused on advancing healthcare solutions and improving global health outcomes.

He is also an Associate Professor at the Faculty of Medicine, Université de Montréal. With a background in pharmacology, R&D, drug development, health economics, and digital transformation, he has expertise in driving innovation and access in the healthcare industry.